Cargando…

The Role of MIF in Type 1 and Type 2 Diabetes Mellitus

Autoimmunity and chronic low-grade inflammation are hallmarks of diabetes mellitus type one (T1DM) and type two (T2DM), respectively. Both processes are orchestrated by inflammatory cytokines, including the macrophage migration inhibitory factor (MIF). To date, MIF has been implicated in both types...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Zamora, Yuriko I., Rodriguez-Sosa, Miriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910331/ https://www.ncbi.nlm.nih.gov/pubmed/24527464 http://dx.doi.org/10.1155/2014/804519

Ejemplares similares

Altered Macrophage and Dendritic Cell Response in Mif−/− Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes
por: Sánchez-Zamora, Yuriko Itzel, et al.
Publicado: (2016)

Macrophage Migration Inhibitory Factor (MIF): A Key Player in Protozoan Infections
por: de Dios Rosado, Juan, et al.
Publicado: (2011)

Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus
por: Yi, Bo, et al.
Publicado: (2016)

Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
por: Park, Sangmi S., et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
por: Tumminia, Andrea, et al.
Publicado: (2018)

Variables to Be Monitored via Biomedical Sensors for Complete Type 1 Diabetes Mellitus Management: An Extension of the “On-Board” Concept
por: Rodríguez-Rodríguez, Ignacio, et al.
Publicado: (2018)

Diabetic-induced alterations in hepatic glucose and lipid metabolism: The role of type 1 and type 2 diabetes mellitus
por: Jiang, Saizhi, et al.
Publicado: (2020)

Temporal trend of autonomic nerve function and HSP27, MIF and PAI-1 in type 1 diabetes
por: Zimmerman, Malin, et al.
Publicado: (2017)

MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
por: Lee, Eun Ju, et al.
Publicado: (2022)

The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
por: Ahmed, Sanabil Ali Hassan, et al.
Publicado: (2020)

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
por: Soumoy, Laura, et al.
Publicado: (2019)

Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus
por: Zhou, Tong, et al.
Publicado: (2018)

Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus
por: Sha, Wenxin, et al.
Publicado: (2021)

Role of mitochondrial DNA in diabetes Mellitus Type I and Type II
por: Al-Ghamdi, Bandar Ali, et al.
Publicado: (2022)

On type 1 diabetes mellitus pathogenesis
por: Paschou, Stavroula A, et al.
Publicado: (2017)

The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into “Old” Diseases
por: Harsch, Igor Alexander, et al.
Publicado: (2018)

A Narrative Literature Review on the Role of Exercise Training in Managing Type 1 and Type 2 Diabetes Mellitus
por: Piras, Alessandro, et al.
Publicado: (2023)

Smoking and Type 2 Diabetes Mellitus
por: Chang, Sang Ah
Publicado: (2012)

Pathophysiology of Type 2 Diabetes Mellitus
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Role of FoxO1 in regulating autophagy in type 2 diabetes mellitus (Review)
por: Li, Xiudan, et al.
Publicado: (2021)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

On the Possibility of Predicting Glycaemia ‘On the Fly’ with Constrained IoT Devices in Type 1 Diabetes Mellitus Patients
por: Rodríguez-Rodríguez, Ignacio, et al.
Publicado: (2019)

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
por: Anderson, John E., et al.
Publicado: (2016)

The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
por: Shen, Shengnan, et al.
Publicado: (2022)

Role of immune system modulation in prevention of type 1 diabetes mellitus
por: Hassan, Gamal Abdulrhman, et al.
Publicado: (2012)

Role of Host and Parasite MIF Cytokines during Leishmania Infection
por: Holowka, Thomas, et al.
Publicado: (2020)

The potential role of vildagliptin in the management and prevention of type 2 diabetes mellitus
por: Chakraborti, C.K.
Publicado: (2008)

Efficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review
por: Herz, Daniel, et al.
Publicado: (2023)

MIF and MMP-9 Serum Changes in Type II Diabetes and Non-Diabetic Subjects: A Short Communication
por: Rastgoo Haghi, Alireza, et al.
Publicado: (2021)

Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
por: Liu, Jiangman, et al.
Publicado: (2021)

Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
por: Moon, Joon Ho, et al.
Publicado: (2017)

Celiac disease in type 1 diabetes mellitus
por: Camarca, Maria Erminia, et al.
Publicado: (2012)

Cardiovascular Risk in Type 1 Diabetes Mellitus
por: Schofield, Jonathan, et al.
Publicado: (2019)

Teneligliptin in management of type 2 diabetes mellitus
por: Sharma, Surendra Kumar, et al.
Publicado: (2016)

Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Progress in Metabonomics of Type 2 Diabetes Mellitus
por: Ma, Quantao, et al.
Publicado: (2018)

Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Ertugliflozin in the treatment of type 2 diabetes mellitus
por: Marrs, Joel C, et al.
Publicado: (2020)

The Purinergic Landscape of Type 2 Diabetes Mellitus
por: Garcia-Jacobo, Rocio Edith, et al.
Publicado: (2022)

Cardiovascular risk in type 1 diabetes mellitus
por: Slim, Ines Ben Hadj Slama
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nrhac65n5iff0lb2pj5ual8h9u